The 2025-26 Budget: Overview of the Governor's Budget

Jan 13, 2025 - Third, the budget is currently balanced, but only because the Legislature took significant actions last year —nearly all of which involved one ‑time uses of funds, like reserve withdrawals, temporary revenue augmentations, and reductions in temporary spending.
https://lao.ca.gov/Publications/Report/4951

The 2018-19 Budget: Governor's May Revision Medi-Cal Budget

May 14, 2018 - The administration estimates that the total cost of the CA-MMIS modernization project will be between $400  million and $600  million, $40  million to $60  million of which will be General Fund as the project likely qualifies for an enhanced FMAP of 90  percent.
https://lao.ca.gov/Publications/Report/3839

The 2026-27 Budget: Department of Developmental Services

Mar 13, 2026 - In such cases, the consumer would likely need to wait until a provider is available before they can receive the authorized service. Actual utilization can therefore be lower than authorized utilization.
https://lao.ca.gov/Publications/Report/5157

The 2017-18 Budget: Overview of the Governor's May Revision Medi-Cal Budget Proposal

May 17, 2017 - The Governor ’s May Revision budget proposal estimates Medi-Cal General Fund spending in 2016 ‑17 to be $18.9  billion, a $620  million reduction compared to the Governor ’s January budget estimate of General Fund Medi-Cal spending.
https://lao.ca.gov/Publications/Report/3674

The 2026-27 Budget: Medi-Cal Analysis

Mar 2, 2026 - More frequent renewals will likely increase the risk of disenrollment even among otherwise eligible individuals, due to the increased frequency of needing to submit required documentation. Like community engagement requirements, more frequent renewals are also expected to increase administrative workload for county eligibility systems, at least in the short run.
https://lao.ca.gov/Publications/Report/5146

Considering Medi-Cal in the Midst of a Changing Fiscal and Policy Landscape

Oct 24, 2025 - As such, the Legislature likely will want to better understand the needed changes, the time line for DHCS to adopt these changes, and the potential to offset some of these costs using enhanced federal funding.
https://lao.ca.gov/Publications/Report/5083

The 2025-26 Budget: Medi-Cal Pharmacy Spending

Apr 3, 2025 - Different Brands Treat Obesity and Diabetes Glucon ‑Like Peptide ‑1 (GLP ‑1) Agonists Drug
https://lao.ca.gov/Publications/Report/5026

The 2026-27 Budget: Medi-Cal Fiscal Outlook

Nov 19, 2025 - Much like the state budget solutions, many changes are scheduled to become effective in the near future. As a result, as Figure 1 shows, Medi‑Cal faces a steady flow of major state and federal policy changes over the coming years.
https://lao.ca.gov/Publications/Report/5092

The 2025-26 Budget: Health Care Access and Information

Feb 20, 2025 - As of our analysis, however, HCAI indicated that it could not provide an estimated time line to receive federal approval to sell  the product. Naloxone Initiative Appears to Be Moving at Faster Pace.
https://lao.ca.gov/Publications/Report/4979

The 2025-26 California Spending Plan: Health

Oct 16, 2025 - Most notably, the administration plans to end coverage of Glucagon-Like Peptide-1 (GLP-1) agonists used to treat obesity (such as Wegovy). (Medi-Cal will still cover GLP-1s that treat diabetes, such as Ozempic, as required under federal law.)
https://lao.ca.gov/Publications/Report/5075